Background: Ischemia / reperfusion (I / R) leads to the induction of inducible nitric oxide synthase. The present study investigated the effects of selective and continuous inhibition of iNOS on myocardial performance, infarct size and histomorphological changes after I / R in rabbits. Methods and Results: Ischemia / reperfusion (I / R) was induced by occlusion of the circumflex coronary artery for 30 min followed by 48 h of reperfusion. Sham animals (group A) served as control. Three groups were subjected to I / R: (B) placebo; (C) aminoguanidine (AMG; 10 mg / kg bolus) given prior to and 48 h after I / R to test its acute effects; (D) AMG (300 mg / kg / day sc) to test effects of continuous treatment. Hemodynamics, myocardial blood flow, infarct size, iNOS activity, cGMP levels, immunohistochemical analysis of iNOS expression and AMG tissue levels were determined.Continuous AMG treatment improved myocardial performance (hemodynamics and blood flow) compared to placebo group. iNOS was highest in placebo-treated animals. AMG tissue levels were highest in tissues affected by I / R. Infarct size (% of the circumflex region) was significantly smaller in group D when compared to group B. Conclusions: This is the first study showing that activation of myocardial iNOS isozyme during 48 h of reperfusion contributes to a late phase of I / R-induced injury in rabbits. Selective and continuous modulation of iNOS by AMG over this time period exerts protective effects with respect to myocardial performance, coronary blood flow, cellular infiltration and reduction of infarct size; this may be a novel therapeutic approach in the clinical situation to limit irreversible myocardial injury associated with ischemia and reperfusion.
Introduction
modification of the reperfusate [7] [8] [9] . However, injury caused by reperfusion may also occur in later stages (hours Several distinct mechanisms are involved in the detrior days) after initiation of reperfusion. In this regard, mental process of myocardial reperfusion following isinduction and activation of proinflammatory mediators chemic periods; this include neutrophil adhesion to endosuch as cytokines and inducible nitric oxide synthase thelial cells within the microcirculation (leading to 'the no (iNOS) have been shown to contribute to myocardial reflow phenomenon'), excessive increase of intracellular injury [10, 11] . Upregulation of iNOS leads to excess nitric
11
Ca and generation of oxygen-derived free radicals [1-oxide production for prolonged periods of time and may 6]. Several studies have shown, that some of these account for oxyradical-mediated myocardial damage or act detrimental events which take place within seconds or as a negative inotrope due to myocardial cGMP production minutes after initiation of reperfusion were abolished by [12] . Previous studies have shown that the inducible nitric oxide synthase is activated 24 to 72 h after onset of myocardial ischemia and is associated with increased NO production. In addition, we have previously shown that nonisoform selective inhibition of NOS aggravates ischemia-induced myocardial dysfunction. In contrast, the acute administration of isoform selective inhibitors of iNOS exerts beneficial effects on myocardial performance in this model [13] . Selective iNOS inhibitors have also been tested in several other experimental settings in various disease states. The principle idea is the reduction of toxic amounts of iNOS-derived NO in infiltrating inflammatory cells and cardiomyocytes to avoid nonspecific tissue injury and contractile dysfunction while preserving low concentrations of NO released by the endothelial constitutive NOS shown that AMG exerts beneficial effects in several disease states including acute heart and lung allograft rejection and autoimmune myocarditis [14] [15] [16] [17] [18] .
I / R. iNOS activity was measured at 0.5 h (n54), 24 h Based on our previous findings, the present study (n56), 48 h (n57), 72 h (n55), 96 h (n54) and 120 h investigated the hypothesis that a significant increase of (n54). iNOS activity is present 48 h after myocardial ischemia Left ventricular endsystolic pressure (LVESP) response and reperfusion (I / R). In order to confirm, that NO derived to various intravenous concentrations of AMG (1.0, 3.0, from iNOS plays an important role after I / R we investi-10.0 30.0 and 50.0 mg / kg) were determined in additional gated the effects of acute and continuous administration of animals at various time points after I / R (prior to I / R and AMG, a selective iNOS inhibitor, on left ventricular 30 min after I / R: n510; 24 h after I / R: n55; 48 h after hemodynamics, regional myocardial blood flow, infarct I / R: n55) and is shown in Fig. 2 In the placebo group (B) and continuous AMG treatThe experimental protocol was approved by the institument group (D) the myocardial response to the b-adrenotional Animal Care and Use Committee. New Zealand receptor agonist isoproterenol (30 ng / kg) given via a left rabbits were randomly assigned to one of the four groups:
atrial catheter was tested 48 h after I / R in the presence of A (n56): sham; B (n57): ischemia / reperfusion and increased iNOS activation (placebo group) and absence of treatment with placebo (saline; 3.0 ml / sc three times a iNOS activation (continuous AMG treatment). The dose day); C (n56): treatment with aminoguanidine (AMG, assured significant cardiac specific response without sig-10.0 mg / kg / iv bolus) once given upon initiation of nificant systemic effects, which in turn would have rereperfusion (absence of iNOS) and again 48 h after I / R sulted in alterations of the hemodynamic response. (presence of iNOS); D (n59): continuous treatment with
The time interval chosen (48 h after I / R) was based on AMG (300.0 mg / kg / day / sc) over 48 h starting upon the time course of iNOS induction in this model. Inducible reperfusion. The daily dose was divided in three dosages NOS activity significantly increased 24 to 72 h (max. at 48 and dissolved in 3.0 ml saline. The time points chosen for h) after I / R and subsequently decreased over time compardetermination of iNOS-mediated effects on I / R was based able to findings described previously [13] . We hypothon the finding that this isoenzyme was maximally inesized that administration of the inhibitor during the time creased 48 h following I / R suggesting that the inhibitor period of enzyme activation exerted maximal effects on would exert maximal effects on hemodynamics and blood hemodynamics and changes in myocardial blood flow. flow. The time course of iNOS activation in the I / R region Heart rate, left ventricular end systolic (LVESP) and end in this model is depicted in Fig. 1 . For this reason diastolic pressures (LVEDP), mean arterial pressure additional animals were subjected to the same protocol of (MAP), maximum positive and negative dP/dt (1dP/ dt; 2dP/dt), indices of the inotropic state, were monitored of cyanosis and bulging of the anterolateral aspect of the and recorded continuously. Rate pressure product, an index left ventricle documented successful coronary occlusion. of cardiac work (oxygen consumption), was calculated After 30 min of complete ischemia the reperfusion phase from arterial systolic pressure and heart rate. Coronary was initiated by re-opening the occluded artery. The vascular resistance was estimated from the ratio of mean sutures were kept in place without ligation. At the end of arterial blood pressure (mmHg), recorded just before each the experiment the chest was closed in layers and animals microsphere injection, and the corresponding myocardial were inspected daily until their scheduled re-operation. blood flow (ml/g/min).
Measurement of myocardial blood flow 2.2. Surgical preparation
Myocardial blood flow was measured by injecting four Anesthesia was maintained with pentobarbital as dedifferent colors of fluorescent microspheres in random scribed [19] . An 18-g catheter was inserted into the left order at definite time points: (1) when animals had common carotid artery and advanced into the aortic root returned to stable hemodynamic conditions (baseline); (2) for measurement of hemodynamics and withdrawal of after initiation of ischemia, (3) after initiation of reperfureference blood samples. An 18-g catheter was inserted sion and (4) 48 h after I / R. into the left ventricle via the left ventricular apex for Approximately 250 000 fluorescent microspheres (15 continuous measurement of hemodynamics. A 20-g cathemm in diameter; blue, blue-green, yellow-green, orange ter was inserted into the left atrium for injection of or red; Triton Technology, San Diego, CA) were vortexed, microspheres and for administration of isoproterenol in sonicated and injected into the left atrial catheter followed groups B and D. After completion animals were allowed to by a flush of heparinized, prewarmed saline (3.0 ml; 378C) stabilize for 30 min prior to the of start the experimental [13] . Reference blood samples were withdrawn from the protocol.
carotid artery catheter at a rate of 1.36 ml / min (Harvard To produce myocardial ischemia the circumflex corApparatus, Dover, MA) starting 20 s before injection of onary artery was occluded midway between left atrial microspheres for a total of 120 s. During microsphere appendage and apex, using a 4-0 prolene suture. In sham filtration, lipids, triphenyl tetrazolium chloride and Evans animals the suture was kept in place without ligation for blue dye were removed by rinsing filters with a solution later determination of the circumflex region. Appearance consisting of 2% TWEEN 80 in distilled water (60%) and ethyl alcohol (40%). Measurement of emission peaks was alkalinisation of the sample the yellow product was performed using a fluorescence spectrophotometer.
extracted into ethyl acetate and back into an aqueous phase of dilute HCL in the presence of heptane. After alkalinisa-2.4. Determination of infarct size tion by HCL extraction the yellow product was assayed by spectrophotometry. The concentration of AMG (mM) was After euthanasia hearts were removed, mounted on a derived from standards using known amounts of AMG Langendorff apparatus (Hugo Sachs Electronics) and peradded to tissue homogenates and carried through the entire fused with saline for 1 min. To account for the circumflex procedure [22] . region, the suture was re-occluded prior to perfusion. Infarcted regions were determined using triphenyl-tetra-2.8. Immunohistochemical analysis zolium-chloride and Evans Blue Dye [20] . Left ventricular rings were placed between clear overlays and regions were Consecutive sections were washed in PBS (pH 7.4) and traced on paper. Areas were planimetered using approincubated with a primary monoclonal antibody against priate software. Infarct size was expressed as a percentage macrophage iNOS (dilution1:25; Transduction Laboratorof the risk (circumflex) region.
ies, Lexington, KY). In addition, infiltrating mononuclear cells were identified with a monoclonal rabbit anti-macro-2.5. Nitric oxide synthase assay phage (RAM-11; dilution 1:50; DAKO) antibody. The incubation medium consisted of PBS (pH 7.4) containing Approximately 40.0 mg of tissue from the infarcted and 0.4% Triton X-100 and incubation was performed at room non-infarcted regions were homogenized in 1.0 ml of Tris temperature for 1-2 h. Control sections were incubated buffer (0.05 M, pH 7.4). Supernatants were adjusted to a with mouse-serum (dilution 1:100) (Dako Corp.). Visualiprotein content of 2.0 mg / ml using protein assay kit P5656 zation was performed with a fluorescein conjugated anti-(Sigma) with bovine serum albumin as standard, and were mouse IgG and the Vectastain Elite ABC Kit (Vector 14 used for the enzyme activity assay immediately. L-[ C]arLaboratories) [23] . ginine was purified by column cation-exchange chromatography. Constitutive NOS (cNOS) activity was measured in 2.9. Statistical analysis the presence of NADPH (1 mM), calmodulin (30 nM), 11 
Ca
(2 mM) and tetrahydrobiopterin (5 mM) (all from Mean values are shown with their standard deviations Sigma). Inducible NOS (iNOS) was determined in the (SD). Paired t-test was used to assess differences in presence of the above factors and EGTA (5 mM) and hemodynamics and blood flow within each individual 11 without Ca . NOS activity (fmol / mg / min) was linear animal. Analysis of variance (ANOVA) was used to assess with respect to time for at least 30 min. differences between groups. Correlations were determined by single regression analysis. P-values of 0.05 or less were 2.6. Determination of myocardial cGMP levels considered statistically significant.
Left ventricular myocardium was analyzed in duplicates using a radio immunoassay kit (TRK 500 Amersham, 3. Results Arlington Heights, IL). Frozen myocardial samples were homogenized with 0.5 ml of 6% trichloroacetic acid (TCA) 3.1. Effects of AMG on left ventricular hemodynamics at 48C in a glass tissue grinder and centrifuged at 48C (10 000 g; 10 min). The supernatant was removed and
In Sham animals, no significant changes in left ventricuextracted four times with 5 ml of water-saturated diethyl lar and systemic hemodynamics were noted, indicating that ether. The aqueous phase was lyophilized and the residue the surgical procedure per se had no significant effects on was dissolved in 0.3 ml of assay buffer. The protein pellet cardiac function (Table 1) . was solubilized by addition of 1.5 ml of 1 M NaOH for 24
All animals subjected to I / R in groups B, C, D showed h. Cyclic GMP concentration was expressed as pmol / mg a significant reduction in 1dP/dt and increase in LVEDP of protein [21] . The hemodynamic effects of acute and chronic AMG of increased iNOS activation (placebo treatment) and treatment are summarized in Table 1 . Fig. 2 shows the during sufficient iNOS inhibition (continuous AMG treateffects of various concentrations of AMG on LVESP ment) 48 h after I / R. In both groups a significant increase response at various time points. A dose dependent increase in LVESP and 1 / 2 dP/dt was noted (Table 2 ). However, of LVESP to AMG was only observed 48 h after I / R. the percent increase in maximum positive and negative Acute bolus administration of AMG (10.0 mg / kg / iv) 30 dP/dt was significantly higher in AMG-treated animals min after I / R was given to exclude potential nonspecific further supporting that iNOS activation contributes to effects of the drug on cardiovascular hemodynamics in the myocardial dysfunction ( Table 2) . absence of iNOS activation. As shown, at this time no significant changes in LVESP response were observed (Fig. 2) . In contrast, similar doses given 48 h after I / R (in 3.3. Effects of AMG on regional myocardial blood flow the presence of increased iNOS activation) resulted in a and coronary vascular resistance significant pressure response (Fig. 2 ) which was slow in onset and lasted 3-5 min. The effects observed by Myocardial blood flow in left ventricular regions not intravenous bolus of AMG 48 h after I / R did not depend affected by I / R did not differ significantly among groups. on the single dose given at 30 min post I / R. Moreover, the Myocardial blood flow measured 30 min after initiation of effect on LVESP 48 h after I / R was not due to increased reperfusion was significantly lower as compared to sham load, since LVEDP significantly decreased in these animals animals and baseline blood flow determined prior to I / R (Fig. 3B) ( Fig. 4) . A further reduction of myocardial blood flow in In addition, continuous administration of AMG (300.0 the same region was observed in the placebo-treated group mg / kg / day / sc) over 48 h resulted in a significant imdetermined 48 h after I / R. In contrast, administration of provement of myocardial performance (reduced LVEDP, AMG bolus (10.0 mg / kg) as well as continuous AMG increased 1dP/dt) when compared to placebo group (Fig. treatment (300.0 mg / kg / day) restored myocardial blood 3A, B, Table 1 ).
flow to levels comparable to sham animals. In addition, no significant changes in coronary vascular resistance (CVR) 3.
Effects of continuous AMG on left ventricular
were noted in AMG-treated animals as shown in Table 1 .
hemodynamic response to isoproterenol
It is known that high amounts of nitric oxide impair the 3.4. Effects of AMG on myocardial NOS activity response of cardiomyocytes and smooth muscle cells to b-adrenergic stimuli in vitro and in vivo. We tested the Endothelial constitutive NOS (ecNOS) activity tended to effects of isoproterenol (ISO; 30 ng / kg) administered into be decreased in placebo and AMG-treated animals. Howthe left atrium on myocardial contractility in the presence ever, AMG treatment did not significantly affect ecNOS activity in the different animal groups indicating that AMG In addition, AMG continuously administered significantly is selective for iNOS activity in this model (Fig. 5A) .
inhibited iNOS activity (Fig. 5A ). The time course of iNOS activation is shown in Fig. 1 after I / R in placebo-treated animals and were completely Highest AMG concentration was determined in animals blocked by continuous AMG treatment (Fig. 5B ) Elevated which received continuous AMG treatment over 48 h. In cGMP levels were also observed in animals which rethis group, AMG concentration was significantly higher in ceived AMG as bolus (Fig. 5B) .
the affected myocardium when compared to regions not subjected to I / R, indicating a higher uptake of AMG in 3.6. Myocardial aminoguanidine levels regions of increased iNOS expression and activation (Fig.  5C ). One explanation of increased AMG tissue content at In order to confirm that the inhibitor administered the site of inflammation may be the selectivity of the reaches the site of increased iNOS activation within compound to iNOS in this model. myocardial tissue, we measured the AMG concentration in
In addition, there was a strong correlation between the affected myocardium 48 h after I / R. No AMG levels iNOS activation in the placebo group and AMG tissue were detected in sham and placebo-treated animals. In levels in the continuously treated group over time further contrast, a significant amount of AMG within the myocarsupporting the specificity of AMG on iNOS inhibition dium was measured in animals treated with AMG bolus.
( Fig. 5D ) . Myocardial iNOS activity is significantly increased within 48 h after initiation of I / R in the placebo group. Both, bolus and continuous AMG treatment significantly reduces iNOS activity (A). In contrast, endothelial constitutive NOS (ecNOS) activity remains unchanged after I/R1placebo as compared to sham; in addition, both bolus and continuous AMG administration do not exert significant inhibitory effects on ecNOS activity when compared to placebo-treated animals (A). Cyclic guanosine monophosphate (cGMP) levels as measured by RIA increases significantly after 48 h of I / R; cGMP is significantly inhibited by both, acute and continuous AMG treatment (B). AMG tissue distribution is shown in C. No specific signal is detected in sham animals. In addition, measurement of AMG concentration after 48 h of bolus (group C) and continuous AMG treatment (group D) reveals low levels in nonaffected myocardium. In contrast, the myocardium affected by I / R with subsequent upregulation of iNOS shows significant higher AMG tissue levels compared to nonaffected myocardium in the same animals. In particular animals treated continuously show the highest AMG levels in the affected cardiac tissue (C). Moreover, a significant correlation between myocardial iNOS activity and AMG tissue levels over time is found (D); Sham (n56); ischemia / reperfusion (I / R)1placebo (saline; 3.0 ml / sc three times a day (n57); I / R1treatment with aminoguanidine (AMG, 10.0 mg / kg / iv bolus, (n56); I / R1continuous treatment with AMG (300.0 mg / kg / day / sc; n59 In placebo-treated animals, no infarcts were present in Infarct size, expressed as percentage of risk region (RCX the sham group. Animals which received placebo showed region) in placebo group was 62.367%. No significant typical signs of reperfused myocardial infarcts including differences were noted in animals treated with AMG bolus hemorrhage, myocyte coagulation necrosis, contraction (56.768.2%). In contrast, animals which received AMG bands, abundant infiltration of inflammatory cells and continuously (300.0 mg / kg / day / sc) had significantly calcification (Fig. 7A ). Animals treated with AMG showed smaller infarcts (percentage of the risk region) when similar signs of reperfused infarcts (Fig. 7E) . There was way is activated contributing to left ventricular dysfunction and extent of infarct size. Moreover, the deleterious effects mediated by iNOS activation are reversed by continuous isoform selective inhibition of this isoenzyme leading to a significant reduction of infarct size, an important determinant of survival after myocardial injury. The data presented here indicate that the delayed augmentation of nitric oxide production by activation of iNOS late after initiation of reperfusion leads to a NO-dependent myocardial injury which contrasts an early myocardial and endothelial damage caused at least in part by an impaired endothelial production / release of NO. The investigational drug aminoguanidine used in this study is a nucleophilic hydrazine derivative and a selective iNOS inhibitor in vitro and in vivo [18, 24] . A recent study animal models has been shown by Beaven et al [22] . As (Figs. 2, 3) , enhances myocardial blood flow (Fig. 4) , most likely due to the improvement of the hemodynamic state of less infiltration of inflammatory cells noted in animals the myocardium and without significant effects on CVR; it treated with AMG continuously over 48 h (Fig. 7F, G) reduces infarct size when given continuously over a time when compared to those treated with placebo (Fig. 7B, C) .
period of 48 h after initiation of reperfusion (Fig. 6 ) and leads to a reduction of the cellular infiltrate within the 3.9. Immunohistochemical analysis affected regions (Fig. 7) . Acute, intravenous administration of AMG early after Specific immunoreactivity for macrophages and iNOS reperfusion (absence of iNOS activity) does not exert were absent in hearts of sham operated animals (not specific effects on myocardial function indicating that the shown).
drug does not inhibit endothelial cNOS activity; this would A large number of infiltrating mononuclear cells (RAMhave resulted in an increase in blood pressure and systemic 11) were identified in placebo-treated animals subjected to vascular resistance and reduction of myocardial blood flow I / R (Fig. 7B, C) . Consecutive sections revealed distinct due to vasoconstrictive effects. However, a significant iNOS expression in these cells (Fig. 7D) . There was no pressure response, improvement of cardiac performance significant immunostaining for iNOS detected in carand enhanced myocardial blood flow is observed when diomyocytes.
aminoguanidine is given in the presence of increased iNOS Animals treated with AMG showed significantly less activation 48 h after I / R (Fig. 1) . The time course of iNOS infiltration of inflammatory cells when compared to activation (Fig. 1 ) and the fact that AMG bolus administraplacebo-treated animals (Fig. 7F, G) . Immunohistochemition did not exert significant beneficial effects on hemocal analysis revealed that these cells were positive for dynamics and blood flow 24 h after I / R suggests that there iNOS expression 48 h after I / R (Fig. 7H) .
is a certain time window in which the selective inhibition of iNOS is protective on the myocardium. However, this cannot be clearly identified from the present data; the fact 4. Discussion that the isoenzyme is regulated by protein de novo synthesis within hours upon I / R suggests that initiation of The novel and clinically important finding of the present therapy at certain time points after I / R results in protective study is that late after ischemia and reperfusion, the high effects with regard to hemodynamics, histological changes output inducible nitric oxide synthase (iNOS) / NO pathand infarct size. 37] . In addition, Amrani and co-workers dysfunction demonstrated that impaired nitric oxide release is associated with reduction of coronary flow following ischemia Previous studies from our and other laboratories have reperfusion [38] . There is evidence that in the early phase shown that increased iNOS activation parallels an enafter reperfusion the receptor-dependent production of hanced production of myocardial cyclic guanosine monoendothelium derived nitric oxide is impaired, or that nitric phosphate (cGMP), a second messenger which acts as a oxide scavenging is enhanced due to increased production negative inotrope on cardiomyocytes [13] . In this regard, of oxyradicals including superoxide [39, 40] . Further supJoe et al. reported that iNOS-mediated cardiac myocyte port for the involvement of an altered L-arginine / nitric contractile dysfunction is mediated by a decrease in oxide pathway in endothelial dysfunction is provided by intracellular cAMP levels, which is at least in part mePernow et al. and Hiramatsu et al.; they showed, that diated by a cGMP-dependent mechanism [21] . Moreover, L-arginine treatment resulted in enhanced myocardial in patients with heart failure but not in healthy controls, protection and improvement of endothelial function in pigs inhibition of nitric oxide synthase potentiated the response [41, 42] . Other methods of preservation of cardiac endoof the myocardium to b-adrenergic stimulation [26] .
Potential mechanisms of iNOS-mediated myocardial
thelial NO production / release have been described, includAminoguanidine is known to selectively inhibit cGMP ing exposure of hearts to heat stress and modulation of the levels produced by iNOS as shown in endotoxemic rats temperature during cardioplegic arrest [43, 44] . These [24, 27] . As shown here, animals treated with AMG over a findings indicate that early after I / R the availability of NO time period of 48 h showed a significant reduction of is impaired resulting in alterations of coronary flow and myocardial cGMP production and a significant improveflow reserve under these conditions. ment of cardiac contractile function.
However, increased NO production due to activation of Other iNOS / NO-mediated factors may also contribute iNOS during the late phase of I / R may also be deleterious to myocardial dysfunction after I / R i.e. formation of for various reasons. As shown in our study, AMG bolus 48 oxyradicals such as peroxynitrite by binding of NO to h after I / R (in the presence of iNOS activation) as well as superoxide, singlet oxygen or to hydrogen peroxide; it may continuous treatment improved cardiac performance and lead to cytotoxic effects on adjacent cardiomyocytes due to led to an increase in blood flow. In addition, as shown in initiation of lipid peroxidation, inhibition of mitochondrial Table 1 , AMG treatment did not exert significant changes 1 respiratory chain enzymes, inhibition of membrane Na / in coronary vascular resistance, which confirms that the 1 K -ATPase activity, or inactivation of sodium membrane ecNOS activity and ecNOS derived NO production / release channels [28] [29] [30] [31] [32] . Nitric oxide may also enhance oxyradiwas not inhibited. The increase in myocardial blood flow cal production via release of iron from ferritin [33] .
as observed in our study is therefore not due to direct Moreover, recent evidence suggests that cytokine stimueffects of AMG on the endothelial NOS but rather due to lated iNOS activity may also contribute to the decline in improvement of left ventricular hemodynamics leading to a velocity of myocyte shortening due to a decrease in reduction in wall stress. Moreover, the inhibitory effect of 21 sensitivity of the myofilaments to [Ca ] [34] . This is AMG on cGMP production may also contribute to imsupported by the observation that components of the NO proved regulation of regional blood flow. Similar findings pathway downstream to NO appear to desensitize cardiac have been shown by Avontuur et al. They reported that 21 myofilaments to [Ca ] , an effect, which is, at least in part high amounts of myocardial NO production during endomediated by phosphorylation of troponin I [35] . toxemia resulted in autoregulatory dysfunction and altered reactive hyperemia which were reversed by NOS inhibition 4.2. Effects of iNOS on myocardial blood flow late after [45] . ischemia /reperfusion
In addition, Worral et al. reported that AMG treatment prevented vascular barrier dysfunction in a rat model of Several studies have investigated the effects of endoacute allograft rejection by inhibition of enhanced iNOS thelium derived nitric oxide release on coronary vasomotor activity; this resulted in a significant reduction of function in the early phase after ischemia and reperfusion. perivascular edema formation and improved organ function In this regard, Quillen et al. showed that 1 h of ischemia [46] ; it suggests that iNOS-derived NO alters vascular followed by 1 h of reperfusion resulted in a marked homeostasis and blood flow regulation. In this regard, Wu reduction of endothelium-dependent response in the corand colleagues demonstrated that the vascular hyporeaconary microcirculation in dogs [36] . In addition, Bolli and tivity of aortic rings from LPS-treated rats was reversed by colleagues found a prolonged impairment of the vasodilat-AMG administration without affecting the response of or responsiveness and a prolonged increase in vascular these vessel rings to endothelium dependent (ecNOS-deresistance after a reversible (15 min) ischemic injury. This pendent) vasodilations, suggesting that iNOS activation is was unrelated to the contractile depression and the authors directly involved in circulatory failure in this model [17] . suggested that a microvascular stunning in addition to
In contrast to AMG, L-NAME did have significant inhibmyocardial stunning might have developed which lasted itory effects on acetylcholine-induced vasodilations as shown by Joly et al. [47] . These findings suggest that cell migration or influences induction of pro-inflammatory selective inhibition of iNOS may lead to improved blood cytokines as a main stimulus for regional cell migration. flow and flow reserve under conditions of acute inflammaHowever, it seems likely that inhibition of massive cytotion.
toxic NO production in cells infiltrating the infarcted Interestingly, myocardial blood flow after acute adminisregion may limit the amount of non-salvageable tissue tration of AMG bolus was comparable to values obtained damage which in turn results in reduction of further in the continuously treated group. The fact that the last cellular infiltration. Subsequent reduction of enzyme acsubcutaneous dose of AMG (100 mg / kg) was given 4 h tivity, NO and cGMP production as observed in our study prior to flow measurement indicates that the drug may (Fig. 3B) may explain, at least in part, the improvement of have a lasting effect. This is in line with the pharmacologic myocardial function and reduction in infarct size. profile of the drug as described by Beaven et al. and Foote In contrast to these observations, several investigators and co-workers [22, 25] .
have shown that iNOS expression plays a protective role in ischemic and pharmacological preconditioning. Tosaki and 4.3. iNOS-mediated effects on cardiac function:
co-workers reported expression of iNOS mRNA by premyocardial dysfunction versus myocardial protection treatment with Monophosphoryl Lipid A (MLA) which was associated with improved postischemic functional Several recent findings suggest that iNOS activation in recovery of isolated rat hearts [50] . In this study, the myocardial tissues may exert different effects on organ beneficial effect of MLA was inhibited by L-nitro-argininefunction.
methyl-ester (L-NAME) further supporting that the NO Worral and co-workers showed that continuous inhibipathway might be involved [50] . A major difference in the tion of iNOS by AMG prolonged graft survival [15] . study design as compared to the present study may explain Hirono and co-workers showed that under conditions of the intriguing findings. The authors used a non-isoform acute inflammation in a rat model of myocarditis adminisselective NOS inhibitor to account for iNOS-mediated tration of AMG significantly reduced iNOS activity, the effects on myocardial performance; some of the detrimenamount of inflammatory cells and improved cardiac hemotal effects mediated by L-NAME may have been caused by dynamics when compared to non-treated rats [14] .
significant inhibition of endothelial constitutive NOS, Ishiyama and colleagues reported a significant inhibition of thereby leading to reduction of organ blood flow and flow superoxide release and nitrotyrosine formation in AMGreserve, reduction of LV dP/dt as well as the increased treated rats. In line with these findings they also showed a incidence of ventricular arrhythmias [50] . In this regard, significant reduction of the CK-MB levels and improvevarious other investigators have shown that inhibition of ment of hemodynamics indicating a reduction of myocarecNOS leads to a significant reduction in organ blood flow dial cell damage by inhibition of iNOS-mediated formation associated with impaired organ function in increased of oxyradicals such as peroxynitrite. Their histomormortality [51] . phological analysis revealed a significant reduction in As reviewed by Elliot et al., MLA-mediated cardiomyocardial inflammation, reduced cellular infiltrate and protection involves various biochemical endpoints such as absence of nitrotyrosine staining in animals treated with adenosine, heat shock protein 70, catalase, manganous AMG, indicating expression of iNOS but only minimal superoxide dismutase, adenosine kinase and others sugproduction of iNOS derived NO. They concluded from gesting that various factors may be involved in the their findings that AMG selectively inhibits iNOS-mebeneficial effects of these drugs on heart function [52] . diated production of the potent radical peroxynitrite [48] .
Further research is therefore necessary to account for the In line with these findings, immunohistochemical analyvarious mechanisms in which NO production under sis revealed distinct iNOS expression in infiltrating macropathological conditions is protective or needs to be inphages within the affected myocardium. No specific imhibited to prevent further tissue damage. The design of munoreactivity was noted in cardiomyocytes. As shown in new, more selective inhibitors of the NOS isoforms will Fig. 7 there were significantly less cellular infiltrate in certainly help to understand the various effects of NO in animals treated with AMG when compared to placebo different disease states which enables us to more spegroup. Even though infiltrating mononuclear cells in the cifically direct the endogenous NO pathway into a therainfarcted regions of AMG-treated animals expressed iNOS peutic tool. (Fig. 7H) , overall iNOS activity was significantly reduced. This was most likely caused by direct effects of AMG on 4.4. Study limitations iNOS and also due to the reduction of the cellular infiltrate within the region affected by I / R. Similar findings were Aminoguanidine is a non-amino acid analogue of Lreported by others [46, 49] .
arginine and a selective iNOS inhibitor in vivo. However, The mechanism, which leads to reduction of infiltrating it can not be excluded that AMG exerts other iNOS inflammatory cells in the AMG group, remains unclear. It independent effects, which may be of benefit after I / R. is not known whether or not AMG exerts direct effects on
In this regard, in a recent study by Picard and co- 
